<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
DARE
Dare Bioscience
$
()


  • Fly Intel: Pre-market Movers

    Today - 08:59am
  • Dare Bioscience reports FY23 EPS (35c), consensus (38)

    Today - 08:06am
  • Biotech Alert: Searches spiking for these stocks today

    2/26/2024 - 11:01am
  • Dare Bioscience to present additional data from Phase 2b RESPOND study

    2/22/2024 - 08:18am
  • Dare Bioscience announces completion of end-of-Phase 2 meeting with U.S. FDA

    1/31/2024 - 08:02am
  • Dare Bioscience CFO Walters-Hoffert to retire

    1/26/2024 - 16:33pm
  • Dare Bioscience announces grant from Bill & Melinda Gates Foundation

    1/17/2024 - 08:04am
  • Dare Bioscience achieves technological proof of concept for DARE-LARC1

    1/4/2024 - 08:02am
  • Dare Bioscience secures $12M in royalty-backed investment structure

    12/26/2023 - 08:05am
  • Dare Bioscience announces PK, exploratory efficacy results from DARE-PDM1 study

    12/20/2023 - 08:16am
  • Dare Bioscience announces Notice of Award of grant from NICHD for DARE-PTB1

    12/13/2023 - 08:02am
  • Dare Bioscience announces FDA clearance of IND application for DARE-VVA1

    12/7/2023 - 08:04am
  • Dare Bioscience commences Phase 3 study of Ovaprene

    12/4/2023 - 08:15am
  • Dare Bioscience, Premier Research extend strategic partnership

    11/20/2023 - 08:09am
  • Dare Bioscience to present Phase 2b results of Sildenafil Cream in FSAD

    11/13/2023 - 08:40am
dynamic_feed Breaking News